Global Markets Direct: Market Research Reports

Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.

A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.

The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.

With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.

Under the supervision of skillful managers and experts, business analysts produce reports that include:

Product portfolio
Potentially strong market reviews
Competitive analytics
Prospect partners
Mergers and acquisitions project data
Latest trends across a particular industry area
Research and development strategies
The analysis of new customers
A set of remedial measures for projects

They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.

Publications found: 5,853

Sort by:

Voltage Dependent Anion Selective Channel Protein 1 (Outer Mitochondrial Membrane Protein Porin 1 or Plasmalemmal Porin or Porin 31HL or VDAC1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Voltage Dependent Anion Selective Channel Protein 1 (Outer Mitochondrial Membrane Protein Porin 1 or Plasmalemmal Porin or Porin 31HL or VDAC1) Drugs in Development by Therapy Areas and Indications, S...

May 2022 36 pages

Voltage Dependent N Type Calcium Channel Subunit Alpha 1B (Voltage Gated Calcium Channel Subunit Alpha Cav2.2 or Brain Calcium Channel III or CACNA1B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Voltage Dependent N Type Calcium Channel Subunit Alpha 1B (Voltage Gated Calcium Channel Subunit Alpha Cav2.2 or Brain Calcium Channel III or CACNA1B) Drugs in Development by Therapy Areas and Indicat...

May 2022 36 pages

Werner Syndrome ATP Dependent Helicase (DNA Helicase RecQ Like Type 3 or Exonuclease WRN or RecQ Protein Like 2 or WRN or EC 3.6.4.12) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Werner Syndrome ATP Dependent Helicase (DNA Helicase RecQ Like Type 3 or Exonuclease WRN or RecQ Protein Like 2 or WRN or EC 3.6.4.12) Drugs in Development by Therapy Areas and Indications, Stages, Mo...

May 2022 38 pages

16S Ribosomal RNA (16S rRNA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

16S Ribosomal RNA (16S rRNA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY 16S Ribosomal RNA (16S rRNA) Drugs in Development by Therapy...

May 2022 71 pages

23S Ribosomal RNA (23S rRNA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

23S Ribosomal RNA (23S rRNA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY 23S Ribosomal RNA (23S rRNA) Drugs in Development by Therapy...

May 2022 61 pages

30S Ribosomal Subunit (30S RNA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

30S Ribosomal Subunit (30S RNA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY 30S Ribosomal Subunit (30S RNA) Drugs in Development by T...

May 2022 44 pages

3C Like Proteinase (3CL-PRO or 3CLp or EC 3.4.22.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

3C Like Proteinase (3CL-PRO or 3CLp or EC 3.4.22.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY 3C Like Proteinase (3CL-PRO or 3CLp or...

May 2022 79 pages

5-Hydroxytryptamine Receptor 1A (5 HT1A or G 21 or Serotonin Receptor 1A or HTR1A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

5-Hydroxytryptamine Receptor 1A (5 HT1A or G 21 or Serotonin Receptor 1A or HTR1A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY 5-Hydr...

May 2022 119 pages

5-Hydroxytryptamine Receptor 1B (5 HT1B or S12 or Serotonin 1D Beta Receptor or Serotonin Receptor 1B or HTR1B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

5-Hydroxytryptamine Receptor 1B (5 HT1B or S12 or Serotonin 1D Beta Receptor or Serotonin Receptor 1B or HTR1B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type a...

May 2022 53 pages

5-Hydroxytryptamine Receptor 1D (5 HT1D or Serotonin 1D Alpha Receptor or Serotonin Receptor 1D or HTR1D) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

5-Hydroxytryptamine Receptor 1D (5 HT1D or Serotonin 1D Alpha Receptor or Serotonin Receptor 1D or HTR1D) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key...

May 2022 54 pages

5-Hydroxytryptamine Receptor 2 (5 HT2 Receptor or HTR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

5-Hydroxytryptamine Receptor 2 (5 HT2 Receptor or HTR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY 5-Hydroxytryptamine Receptor 2 (5...

May 2022 200 pages

5-Hydroxytryptamine Receptor 2A (5 HT2A or Serotonin Receptor 2A or HTR2A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

5-Hydroxytryptamine Receptor 2A (5 HT2A or Serotonin Receptor 2A or HTR2A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY 5-Hydroxytrypt...

May 2022 169 pages

5-Hydroxytryptamine Receptor 2C (5 HT2C or 5 Hydroxytryptamine Receptor 1C or Serotonin Receptor 2C or HTR2C) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

5-Hydroxytryptamine Receptor 2C (5 HT2C or 5 Hydroxytryptamine Receptor 1C or Serotonin Receptor 2C or HTR2C) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and...

May 2022 58 pages

5-Hydroxytryptamine Receptor 3 (5HT3 or 5 HT3 Receptor or HTR3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

5-Hydroxytryptamine Receptor 3 (5HT3 or 5 HT3 Receptor or HTR3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY 5-Hydroxytryptamine Recep...

May 2022 56 pages

5-Hydroxytryptamine Receptor 4 (5 HT4 or Serotonin Receptor 4 or HTR4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

5-Hydroxytryptamine Receptor 4 (5 HT4 or Serotonin Receptor 4 or HTR4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY 5-Hydroxytryptamin...

May 2022 43 pages

5-Hydroxytryptamine Receptor (Serotonin Receptor or 5 HT Receptor or HTR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

5-Hydroxytryptamine Receptor (Serotonin Receptor or 5 HT Receptor or HTR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY 5-Hydroxytrypta...

May 2022 303 pages

50S Ribosomal Subunit (50S RNA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

50S Ribosomal Subunit (50S RNA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY 50S Ribosomal Subunit (50S RNA) Drugs in Development by T...

May 2022 37 pages

70 kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

70 kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY 70 kDa Ribosomal Protein S6 Ki...

May 2022 37 pages

Acetyl CoA Carboxylase 2 (ACC2 or ACC Beta or ACACB or EC 6.4.1.2 or EC 6.3.4.14) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Acetyl CoA Carboxylase 2 (ACC2 or ACC Beta or ACACB or EC 6.4.1.2 or EC 6.3.4.14) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Acetyl...

May 2022 36 pages

Acetyl CoA Carboxylase (Acetyl Coenzyme A Carboxylase or ACC or EC 6.4.1.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Acetyl CoA Carboxylase (Acetyl Coenzyme A Carboxylase or ACC or EC 6.4.1.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Acetyl CoA Ca...

May 2022 43 pages

Achromatopsia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Achromatopsia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Achromatopsia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...

May 2022 36 pages

Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type A Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type A Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Acid Sphingomyelinase Deficiency (Niemann-Pick Di...

May 2022 37 pages

Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type B Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type B Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Acid Sphingomyelinase Deficiency (Niemann-Pick Di...

May 2022 38 pages

Acquired (Autoimmune) Hemolytic Anemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Acquired (Autoimmune) Hemolytic Anemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Acquired (Autoimmune) Hemolytic Anemia Drugs in Development by Stages, Ta...

May 2022 210 pages

Acral Lentiginous Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Acral Lentiginous Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Acral Lentiginous Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule...

May 2022 35 pages

Acute Bronchitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Acute Bronchitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Acute Bronchitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...

May 2022 35 pages

Acute Coronary Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Acute Coronary Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Acute Coronary Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 54 pages

Acute Heart Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Acute Heart Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Acute Heart Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 51 pages

Acute Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Acute Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Acute Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 45 pages

Acute Ischemic Stroke Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Acute Ischemic Stroke Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Acute Ischemic Stroke Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...

May 2022 114 pages

Acute Liver Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Acute Liver Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Acute Liver Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 46 pages

Acute Lung Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Acute Lung Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Acute Lung Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 80 pages

Acute Lymphoblastic Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Acute Lymphoblastic Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Acute Lymphoblastic Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Mole...

May 2022 45 pages

Acute Opioid Overdosage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Acute Opioid Overdosage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Acute Opioid Overdosage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 43 pages

Acute Promyelocytic Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Acute Promyelocytic Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Acute Promyelocytic Leukemia Drugs in Development by Stages, Target, MoA, RoA, Mole...

May 2022 40 pages

Acute Respiratory Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Acute Respiratory Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Acute Respiratory Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 35 pages

Acute Sensorineural Hearing Loss Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Acute Sensorineural Hearing Loss Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Acute Sensorineural Hearing Loss Drugs in Development by Stages, Target, MoA, R...

May 2022 47 pages

Acute Spinal Cord Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Acute Spinal Cord Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Acute Spinal Cord Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...

May 2022 42 pages

Addiction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Addiction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Addiction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an...

May 2022 295 pages

Adenocarcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Adenocarcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Adenocarcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players pr...

May 2022 116 pages

Adenocarcinoma Of The Gastroesophageal Junction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Adenocarcinoma Of The Gastroesophageal Junction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Adenocarcinoma Of The Gastroesophageal Junction Drugs in Develop...

May 2022 250 pages

Adenoid Cystic Carcinoma (ACC) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Adenoid Cystic Carcinoma (ACC) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Adenoid Cystic Carcinoma (ACC) Drugs in Development by Stages, Target, MoA, RoA,...

May 2022 60 pages

Adenosine Monophosphate Activated Protein Kinase ([Hydroxymethylglutaryl CoA Reductase (NADPH)] Kinase or AMPK or EC 2.7.11.31) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Adenosine Monophosphate Activated Protein Kinase ([Hydroxymethylglutaryl CoA Reductase (NADPH)] Kinase or AMPK or EC 2.7.11.31) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA,...

May 2022 103 pages

Adenosine Receptor A1 (ADORA1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Adenosine Receptor A1 (ADORA1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Adenosine Receptor A1 (ADORA1) Drugs in Development by The...

May 2022 47 pages

Adenosine Receptor A2a (ADORA2A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Adenosine Receptor A2a (ADORA2A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Adenosine Receptor A2a (ADORA2A) Drugs in Development by...

May 2022 80 pages

Adenoviridae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Adenoviridae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Adenoviridae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 57 pages

Adiponectin Receptor Protein 1 (Progestin And AdipoQ Receptor Family Member I or ADIPOR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Adiponectin Receptor Protein 1 (Progestin And AdipoQ Receptor Family Member I or ADIPOR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY...

May 2022 38 pages

ADP Ribosyl Cyclase-Cyclic ADP Ribose Hydrolase 1 (Cyclic ADP Ribose Hydrolase 1 or T10 or 2 Phospho ADP Ribosyl Cyclase-2 Phospho Cyclic ADP Ribose Transferase or ADP Ribosyl Cyclase 1 or CD38 or EC 3.2.2.6 or EC 2.4.99.20) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

ADP Ribosyl Cyclase-Cyclic ADP Ribose Hydrolase 1 (Cyclic ADP Ribose Hydrolase 1 or T10 or 2 Phospho ADP Ribosyl Cyclase-2 Phospho Cyclic ADP Ribose Transferase or ADP Ribosyl Cyclase 1 or CD38 or EC...

May 2022 49 pages

ADP Ribosylation Factor 6 (ARF6) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

ADP Ribosylation Factor 6 (ARF6) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY ADP Ribosylation Factor 6 (ARF6) Drugs in Development by...

May 2022 36 pages

Adrenal Gland Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Adrenal Gland Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Adrenal Gland Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...

May 2022 68 pages